BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...Ltd. raised RMB100 million in an undisclosed round co-led by Delos Capital and Oriza Seed. HuaGai Capital...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...Sequoia Capital China, Alwin Capital, Kunlun Capital and existing investors IDG Capital, Lilly Asia Venture, Huagai Capital...
BioCentury | Jun 16, 2020
Finance

June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun

...raises $58M B round ImmVira Co. Ltd. raised a $58 million series B led by Huagai Capital...
...Medical Fund under the management of CCB International and previous investors China Creation Ventures and Huagai Capital...
BioCentury | Dec 17, 2019
Financial News

Dec. 17 Financial Quick Takes: Lilly sets 2020 guidance; plus JOINN, ArcherDX, KeChow, Aelis and ICT

...series A JOINN Biologics Inc. raised $60 million in a series A round led by Huagai Capital...
BioCentury | May 8, 2019
Financial News

May 8 Financial Quick Takes: Trevi IPO, BMS, GeneQuantum

...Ltd. (Suzhou, China) closed a pre-series B round of financing at RMB100 million ($14.8 million). Huagai Capital...
BioCentury | Mar 15, 2019
Finance

HaiHe's listing recipe

...raised by HaiHe could position the Shanghai-based company to go public this year, lead investor Huagai Capital...
...PDGF receptor B; VEGFR-2 (KDR/Flk-1) - VEGF receptor 2 Hongjiang Li, Staff Writer Shanghai HaiHe Pharmaceutical Co. Ltd. Huagai Capital...
BioCentury | Feb 21, 2019
Financial News

Shukun raises RMB200M series B round for AI diagnostics

...B round led by China Creation Ventures. Two A round investors, Morningside Venture Capital and Huagai Capital...
BioCentury | Feb 13, 2019
Financial News

HaiHe raises $147M in series B to advance cancer candidates

...Feb. 11 to advance its oncology focused pipeline in a series B round led by Huagai Capital...
BioCentury | Feb 11, 2019
Financial News

HaiHe raises $147M in series B to advance cancer candidates

...$146.6 million to advance its oncology focused pipeline in a series B round led by Huagai Capital...
BioCentury | Aug 10, 2018
Financial News

Lilly Asia Ventures leads $15M EdiGene round

...about $15 million in a preseries B round led by Lilly Asia Ventures. New investor Huagai Capital...
Items per page:
1 - 10 of 10
BioCentury | Dec 31, 2020
Finance

Dec. 30 Quick Takes: Transcenta leads year-end crop of China venture rounds

...Ltd. raised RMB100 million in an undisclosed round co-led by Delos Capital and Oriza Seed. HuaGai Capital...
BioCentury | Oct 13, 2020
Finance

Oct. 13 Quick Takes: Sovereign wealth fund backs Evotec; plus Canaan, EdiGene, Cedilla, Rappta and Lassogen

...Sequoia Capital China, Alwin Capital, Kunlun Capital and existing investors IDG Capital, Lilly Asia Venture, Huagai Capital...
BioCentury | Jun 16, 2020
Finance

June 15 Quick Takes: RA makes $200M investment in Novavax; plus venture rounds for Shattuck, ImmVira, Glyscend and Shukun

...raises $58M B round ImmVira Co. Ltd. raised a $58 million series B led by Huagai Capital...
...Medical Fund under the management of CCB International and previous investors China Creation Ventures and Huagai Capital...
BioCentury | Dec 17, 2019
Financial News

Dec. 17 Financial Quick Takes: Lilly sets 2020 guidance; plus JOINN, ArcherDX, KeChow, Aelis and ICT

...series A JOINN Biologics Inc. raised $60 million in a series A round led by Huagai Capital...
BioCentury | May 8, 2019
Financial News

May 8 Financial Quick Takes: Trevi IPO, BMS, GeneQuantum

...Ltd. (Suzhou, China) closed a pre-series B round of financing at RMB100 million ($14.8 million). Huagai Capital...
BioCentury | Mar 15, 2019
Finance

HaiHe's listing recipe

...raised by HaiHe could position the Shanghai-based company to go public this year, lead investor Huagai Capital...
...PDGF receptor B; VEGFR-2 (KDR/Flk-1) - VEGF receptor 2 Hongjiang Li, Staff Writer Shanghai HaiHe Pharmaceutical Co. Ltd. Huagai Capital...
BioCentury | Feb 21, 2019
Financial News

Shukun raises RMB200M series B round for AI diagnostics

...B round led by China Creation Ventures. Two A round investors, Morningside Venture Capital and Huagai Capital...
BioCentury | Feb 13, 2019
Financial News

HaiHe raises $147M in series B to advance cancer candidates

...Feb. 11 to advance its oncology focused pipeline in a series B round led by Huagai Capital...
BioCentury | Feb 11, 2019
Financial News

HaiHe raises $147M in series B to advance cancer candidates

...$146.6 million to advance its oncology focused pipeline in a series B round led by Huagai Capital...
BioCentury | Aug 10, 2018
Financial News

Lilly Asia Ventures leads $15M EdiGene round

...about $15 million in a preseries B round led by Lilly Asia Ventures. New investor Huagai Capital...
Items per page:
1 - 10 of 10